Class 2 Drug Alert – Merck Sharp & Dohme Limited: Zerbaxa (tazobactam/ceftolozane) 1g/0.5g powder for concentrate for solution for infusion, EU/1/15/1032/001

Specific batches are being recalled temporarily whilst investigations into microbiological quality are underway; due to presence of Ralstonia pickettii in recent batches manufactured. All stock of listed batches should be quarantined immediately and returned to supplier.

Medicines and Healthcare products Regulatory Agency